Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018

SELL
$88.86 - $117.49 $3.79 Million - $5.02 Million
-42,705 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$99.64 - $127.59 $1.06 Million - $1.36 Million
10,629 Added 33.14%
42,705 $6.7 Million
Q1 2018

May 15, 2018

SELL
$105.8 - $150.94 $2.6 Million - $3.71 Million
-24,586 Reduced 43.39%
32,076 $5.48 Million
Q4 2017

Feb 14, 2018

SELL
$81.25 - $130.7 $1.19 Million - $1.92 Million
-14,667 Reduced 20.56%
56,662 $10.1 Million
Q3 2017

Nov 13, 2017

BUY
$57.74 - $91.42 $4.12 Million - $6.52 Million
71,329
71,329 $9.8 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $35.5M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.